NCT06166030View on ClinicalTrials.gov

IMMUNERECOV CONTRIBUTES TO IMPROVEMENT OF RESPIRATORY AND IMMUNOLOGICAL RESPONSE IN POST-COVID-19 PATIENTS.

PHASE3RecruitingINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

December 10, 2023

Primary Completion Date

December 10, 2024

Study Completion Date

December 15, 2024

Conditions
Long Covid19Dietary SupplementsRespiratory Tract InfectionsInflammation
Interventions
DIETARY_SUPPLEMENT

Nutritional blend (ImmuneRecov).

Effects of 30 days supplementation with ImmuneRecov on Peripheral and Respiratory Muscle Strength, on Lung Function and Immune Response.

Trial Locations (2)

12231280

RECRUITING

Laboratory of Pulmonary and Exercise Immunology, São José dos Campos

12231-280

RECRUITING

Laboratory of Pulmonary and Exercise Immunology - Federal University of Sao Paulo, São José dos Campos

All Listed Sponsors
lead

Federal University of São Paulo

OTHER